News & Events IBS study – new collaborationBiomeDx receives funding from the Austrian Research Promotion Agency (FFG) to investigate the microbiome of…Catia PacificoMay 9, 2023
News & Events Poster: CIMT Annual Meeting 2023BiomeDx presents new insights about the intestinal microbiome and response to immunotherapy at CIMT 2023…Catia PacificoMay 5, 2023
News & Events EIT Health Catapult FinalistBiomeDx advances to finals of EIT Health Catapult Program 2022-2023 VIENNA, 3rd April 2023: BiomeDx…Catia PacificoApril 3, 2023
News & Events Innovationscamp St. PöltenVIENNA, 16th March 2023: BiomeDx, a leader in AI-driven solutions for healthcare and biotech, is…Catia PacificoMarch 16, 2023
News & Events DACH Healthcare Innovation SummitCo-founder Nikolaus Gasche attends DACH Healthcare Innovation Summit 2023 MUNICH, 2-3rd March 2023: Biome Diagnostics…Catia PacificoMarch 3, 2023
News & Events BIGMED-Austria SeminarInsights on Microbiome and Cancer Immunotherapy at BIGMED-Austria Seminar VIENNA, 18th February 2023: Our very…Catia PacificoFebruary 18, 2023
News & Events 100 best startups 2022 in AustriaBiome Diagnostics ranks amongst the best Austrian startups 2022 VIENNA, November 25 For the last…Catia PacificoNovember 25, 2022
News & Events BiomeDx among world’s best startupsVIENNA, 18 November 2022 MARIE, the newsletter from the Austrian Chamber of Commerce (WKO) has…Catia PacificoNovember 18, 2022
News & Events Phönix Awards 2022BiomeDx nominated for Phönix Awards VIENNA, November 7 Biome Diagnostics had the pleasure of participating…Catia PacificoNovember 7, 2022
News & Events Web Summit 2022 LisbonBiome Diagnostics has participated for the first time in the world renowned tech conference Web…Catia PacificoNovember 4, 2022